Drug Absorption Studies.
SCHAFER-KORTING, M., BOCK, U., DIEMBECK, W., DUSING, H. J., GAMER, A., et al. 2008. The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. Altern Lab Anim, 36, 161-87.
SCHMOOK, F. P., MEINGASSNER, J. G. & BILLICH, A. 2001. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm, 215, 51-6.
SCHREIBER, S., MAHMOUD, A., VUIA, A., RUBBELKE, M. K., SCHMIDT, E., et al. 2005. Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro, 19,813-22.
SCHRODER, H., KOMLJENOVIC, D., HECKER, M. & KORFF, T. 2016. Transdermal drug targeting and functional imaging of tumor blood vessels in the mouse auricle. Faseb j, 30, 923-32.
SCOGNAMIGLIO, I., DE STEFANO, D., CAMPANI, V., MAYOL, L., CARNUCCIO, R., et al. 2013. Nanocarriers for topical administration of resveratrol: A comparative study. International Journal of Pharmaceutics, 440, 179-187.
ŞENYIĞIT, T., SONVICO, F., BARBIERI, S., ÖZER, Ö., SANTI, P., et al. 2010. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. Journal of Controlled Release, 142, 368-373.
SHAH, V. P., ELKINS, J., LAM, S.-Y. & SKELLY, J. P. 1989. Determination of in vitro drug release from hydrocortisone creams. International Journal of Pharmaceutics, 53, 53-59.
SHAKEL, Z., NUNES, C., COSTA LIMA, S. A. & REIS, S. 2019. Development of a novel human stratum corneum model, as a tool in the optimization of drug formulations. International Journal of Pharmaceutics,569, 118571.
SHEPHERD, J., LITTLE, M. C. & NICKLIN, M. J. H. 2004. Psoriasis-Like Cutaneous Inflammation in Mice Lacking Interleukin-1 Receptor Antagonist. Journal of Investigative Dermatology, 122,665-669.
SILVA, E., BARREIROS, L., SEGUNDO, M. A., COSTA LIMA, S. A. & REIS, S. 2017. Cellular interactions of a lipid-based nanocarrier model with human keratinocytes: Unravelling transport mechanisms. Acta Biomaterialia, 53, 439-449.
SINGH, A., SINGH, A., SAND, J. M., BAUER, S. J., HAFEEZ, B. B., et al. 2015. Topically applied Hsp90 inhibitor 17AAG inhibits UVR-induced cutaneous squamous cell carcinomas. The Journal of investigative dermatology, 135, 1098-1107.
SINKO, B., GARRIGUES, T. M., BALOGH, G. T., NAGY, Z. K., TSINMAN, O., et al. 2012. Skin-PAMPA: a new method for fast prediction of skin penetration. Eur J Pharm Sci, 45, 698-707.
SINKÓ, B., VIZSERÁLEK, G. & TAKÁCS-NOVÁK, K. 2014. Skin PAMPA: Application in practice. ADMET & DMPK, 2, 191-198.
SOFIA A. COSTA LIMA., R., S. 2018. Nanotechnological approaches in drug absorption through skin topical delivery. In: PUBLISHING, J. S. (ed.) Nanoparticles in Life Sciences and Biomedicine. New York.
SRIRAM, G., ALBERTI, M., DANCIK, Y., WU, B., WU, R., et al. 2018. Full-thickness human skin-on-chip with enhanced epidermal morphogenesis and barrier function. Materials Today, 21, 326-340.
SZABOWSKI, A., MAAS-SZABOWSKI, N., ANDRECHT, S., KOLBUS, A., SCHORPP-KISTNER, M., et al. 2000. c-Jun and JunB Antagonistically Control Cytokine-Regulated Mesenchymal–Epidermal Interaction in Skin.Cell, 103, 745-755.
TABART, J., BALDO, A., VERMOUT, S., LOSSON, B. & MIGNON, B. 2008. Reconstructed interfollicular feline epidermis as a model for the screening of antifungal drugs against Microsporum canis.Veterinary Dermatology, 19, 130-133.
TANAKA, A., AMAGAI, Y., OIDA, K. & MATSUDA, H. 2012. Recent Findings in Mouse Models for Human Atopic Dermatitis. Experimental Animals,61, 77-84.
TANG, T., TANG, J. Y., LI, D., REICH, M., CALLAHAN, C. A., et al.2011. Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened. Clin Cancer Res, 17, 3378-87.
TARASSOLI, S. P., JESSOP, Z. M., AL-SABAH, A., GAO, N., WHITAKER, S., et al. 2018. Skin tissue engineering using 3D bioprinting: An evolving research field. Journal of Plastic, Reconstructive & Aesthetic Surgery, 71, 615-623.
TERNULLO, S., BASNET, P., HOLSÆTER, A. M., FLATEN, G. E., DE WEERD, L., et al. 2018. Deformable liposomes for skin therapy with human epidermal growth factor: The effect of liposomal surface charge.European Journal of Pharmaceutical Sciences, 125,163-171.
TERNULLO, S., DE WEERD, L., FLATEN, G. E., HOLSÆTER, A. M. & ŠKALKO-BASNET, N. 2017a. The isolated perfused human skin flap model: A missing link in skin penetration studies? European Journal of Pharmaceutical Sciences, 96, 334-341.
TERNULLO, S., DE WEERD, L., HOLSÆTER, A. M., FLATEN, G. E. & ŠKALKO-BASNET, N. 2017b. Going skin deep: A direct comparison of penetration potential of lipid-based nanovesicles on the isolated perfused human skin flap model. European Journal of Pharmaceutics and Biopharmaceutics, 121, 14-23.
THANG, N. D., YAJIMA, I., NAKAGAWA, K., TSUZUKI, T., KUMASAKA, M. Y., et al. 2012. A novel hairless mouse model for malignant melanoma. J Dermatol Sci, 65, 207-12.
TJABRINGA, G., BERGERS, M., VAN RENS, D., DE BOER, R., LAMME, E., et al. 2008. Development and validation of human psoriatic skin equivalents. The American journal of pathology, 173,815-823.
TROTTIER, V., MARCEAU-FORTIER, G., GERMAIN, L., VINCENT, C. & FRADETTE, J. 2008. IFATS Collection: Using Human Adipose-Derived Stem/Stromal Cells for the Production of New Skin Substitutes. STEM CELLS,26, 2713-2723.
TSINMAN, K. & SINKÓ, B. 2013. A high throughput method to predict skin penetration and screen topical formulations. Cosmet Toiletries,128, 192-199.
UCHECHI, O., OGBONNA, J. D. N. & ATTAMA, A. A. 2014. Nanoparticles for Dermal and Transdermal Drug Delivery. Application of Nanotechnology in Drug Delivery.
UCHIDA, T., KADHUM, W. R., KANAI, S., TODO, H., OSHIZAKA, T., et al. 2015. Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M. Eur J Pharm Sci, 67,113-118.
UCHIDA, Y. & PARK, K. 2016. Stratum Corneum. In: KABASHIMA, K. (ed.) Immunology of the Skin: Basic and Clinical Sciences in Skin Immune Responses. Tokyo: Springer Japan.
UCHINO, T., TAKEZAWA, T. & IKARASHI, Y. 2009. Reconstruction of three-dimensional human skin model composed of dendritic cells, keratinocytes and fibroblasts utilizing a handy scaffold of collagen vitrigel membrane. Toxicology in Vitro, 23, 333-337.
VAN DEN BROEK, L. J., BERGERS, L., REIJNDERS, C. M. A. & GIBBS, S. 2017. Progress and Future Prospectives in Skin-on-Chip Development with Emphasis on the use of Different Cell Types and Technical Challenges.Stem Cell Rev, 13, 418-429.
VAN GELE, M., GEUSENS, B., BROCHEZ, L., SPEECKAERT, R. & LAMBERT, J. 2011. Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations. Expert Opin Drug Deliv,8, 705-20.
VAN RAVENZWAAY, B. & LEIBOLD, E. 2004. A comparison between in vitro rat and human and in vivo rat skin absorption studies. Hum Exp Toxicol, 23, 421-30.
VESTERGAARD, C., YONEYAMA, H., MURAI, M., NAKAMURA, K., TAMAKI, K., et al. 1999. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis–like lesions. The Journal of Clinical Investigation, 104, 1097-1105.
VIZSERÁLEK, G., BERKÓ, S., TÓTH, G., BALOGH, R., BUDAI-SZŰCS, M., et al. 2015. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method. European Journal of Pharmaceutical Sciences, 76, 165-172.
VORSMANN, H., GROEBER, F., WALLES, H., BUSCH, S., BEISSERT, S., et al. 2013. Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing. Cell Death Dis, 4, e719.
WALTERS, K. A. & ROBERTS, M. S. 2002. The Structure and Function of Skin. Dermatological and Transdermal Formulations. CRC Press.
WANG, H., LI, J., LV, T., TU, Q., HUANG, Z., et al. 2013. Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice.Exp Dermatol, 22, 362-3.
WATKINSON, R. M., GUY, R. H., HADGRAFT, J. & LANE, M. E. 2009a. Optimisation of Cosolvent Concentration for Topical Drug Delivery – II: Influence of Propylene Glycol on Ibuprofen Permeation. Skin Pharmacology and Physiology, 22, 225-230.
WATKINSON, R. M., GUY, R. H., OLIVEIRA, G., HADGRAFT, J. & LANE, M. E. 2011. Optimisation of Cosolvent Concentration for Topical Drug Delivery III – Influence of Lipophilic Vehicles on Ibuprofen Permeation.Skin Pharmacology and Physiology, 24, 22-26.
WATKINSON, R. M., HERKENNE, C., GUY, R. H., HADGRAFT, J., OLIVEIRA, G., et al. 2009b. Influence of Ethanol on the Solubility, Ionization and Permeation Characteristics of Ibuprofen in Silicone and Human Skin. Skin Pharmacology and Physiology, 22, 15-21.
WEINHART, M., HOCKE, A., HIPPENSTIEL, S., KURRECK, J. & HEDTRICH, S. 2019. 3D organ models—Revolution in pharmacological research?Pharmacological Research, 139, 446-451.
WONGLERTNIRANT, N., NGAWHIRUNPAT, T. & KUMPUGDEE-VOLLRATH, M. 2012. Evaluation of the mechanism of skin enhancing surfactants on the biomembrane of shed snake skin. Biol Pharm Bull, 35,523-31.
WORTH, A. P., FENTEM, J. H., BALLS, M., BOTHAM, P. A., CURREN, R. D., et al. 1998. An evaluation of the proposed OECD testing strategy for skin corrosion. Atla-Alternatives to Laboratory Animals, 26, 709-720.
WU, H., DENG, Z., ZHOU, B., QI, M., HONG, M., et al. 2019. Improved transdermal permeability of ibuprofen by ionic liquid technology: Correlation between counterion structure and the physicochemical and biological properties. Journal of Molecular Liquids, 283, 399-409.
WU, S. T., SHIU, G. K., SIMMONS, J. E., BRONAUGH, R. L. & SKELLY, J. P. 1992. In vitro release of nitroglycerin from topical products by use of artificial membranes. J Pharm Sci, 81, 1153-6.
YU, J. R., NAVARRO, J., COBURN, J. C., MAHADIK, B., MOLNAR, J., et al. 2019. Current and Future Perspectives on Skin Tissue Engineering: Key Features of Biomedical Research, Translational Assessment, and Clinical Application. Advanced Healthcare Materials, 8,1801471.
YU, X., DU, L., ZHU, L., LIU, X., ZHANG, B., et al. 2016. Melanoma therapy with transdermal mitoxantrone cubic phases. Drug Deliv, 23, 1565-70.
YUE, L., HUANG, Z. M., FONG, S., LEONG, S., JAKOWATZ, J. G., et al. 2015. Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma. Melanoma Res, 25, 138-48.
YUN, Y. E., JUNG, Y. J., CHOI, Y. J., CHOI, J. S. & CHO, Y. W. 2018. Artificial skin models for animal-free testing. Journal of Pharmaceutical Investigation, 48, 215-223.
ZBYTOVSKÁ, J., KISELEV, M. A., FUNARI, S. S., GARAMUS, V. M., WARTEWIG, S., et al. 2008. Influence of cholesterol on the structure of stratum corneum lipid model membrane. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 328, 90-99.
ZHANG, H., ZHU, X., SHEN, J., XU, H., MA, M., et al. 2016. Characterization of a liposome-based artificial skin membrane for in vitro permeation studies using Franz diffusion cell device.Journal of Liposome Research, 27, 302-311.
ZHANG, Q., SITO, L., MAO, M., HE, J., ZHANG, Y. S., et al. 2018. Current advances in skin-on-a-chip models for drug testing.Microphysiological Systems, 2.
ZHANG, Y., LANE, M. E., HADGRAFT, J., HEINRICH, M., CHEN, T., et al. 2019. A comparison of the in vitro permeation of niacinamide in mammalian skin and in the Parallel Artificial Membrane Permeation Assay (PAMPA) model. International Journal of Pharmaceutics,556, 142-149.